The Food and Drug Administration granted fast track designation to HDP-101 for the treatment of multiple myeloma. The U.S.
Canada has launched a fast-track immigration pathway for H-1B visa holders affected by President Donald Trump’s new $100,000 ...
The US FDA has granted fast track designation to the novel amanitin-based antibody-drug conjugate (ADC) pamlectabart ...
Fast Track Designation was granted for BB-301 following FDA review of positive interim clinical study results and proprietary Responder Analysis ...
Canada has launched a fast-track H-1B visa pathway to attract highly skilled international professionals. Included in the ...
MT-125, a dual small-molecule inhibitor, received FDA fast track designation for glioblastoma, facilitating expedited drug ...